Despite efforts, tumor recurrence is diagnosed in 35–40% of patients with stage III squamous cell lung carcinoma (SCLC) during the first year after treatment. The purpose of the present investigation ...
Schematic view of the experimental techniques followed to study the nanoscale interaction between anti-CYFRA 21-1 bioreceptors over 1DZnO nanoplatforms. In the ongoing battle against cancer, early ...
Despite efforts, tumor recurrence is diagnosed in 35–40% of patients with stage III squamous cell lung carcinoma (SCLC) during the first year after treatment. The purpose of the present investigation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results